NCT00550901View on ClinicalTrials.gov

Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

dexrazoxane hydrochloride

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

OTHER

pharmacological study

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00550901 - Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter